Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Phase 3 × Fludzoparib" and Anti-angiogenic × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 65 Breast Neoplasms 45 Prostatic Neoplasms 28 Neoplasms 25 Multiple Myeloma 24 Lung Neoplasms 19 Parkinson Disease 4, Autosomal Dominant Lewy Body 18 Ovarian Neoplasms 17 Squamous Cell Carcinoma of Head and Neck 16 Leukemia, Lymphocytic, Chronic, B-Cell 16 Myasthenia Gravis 15 Neoplasm Metastasis 14 Leukemia, Myeloid, Acute 14 Colorectal Neoplasms 14 Lymphoma, Follicular 13 Carcinoma, Renal Cell 12 Urinary Bladder Neoplasms 11 Stomach Neoplasms 11 Recurrence 10 Melanoma 10 Carcinoma 10 Small Cell Lung Carcinoma 9 Non-Muscle Invasive Bladder Neoplasms 9 Fallopian Tube Neoplasms 8 Endometrial Neoplasms 8 Lymphoma, Large B-Cell, Diffuse 7 Colonic Neoplasms 7 Uterine Cervical Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Non-Hodgkin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡